What is the survival time taking tucatinib/tucatinib?

Tucatinibhas been approved by the U.S. Food and Drug Administration (FDA ) along with trastuzumab (Herceptin) and capecitabine (Xeloda) for use in adults with HER2positive breast cancer, including cancer that has spread to the brain. Tucatinib is also indicated in combination with trastuzumab for the treatment of adult patients with RAS wild-type HER2-positive unresectable or metastatic colorectal cancer who have progressed on fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy.

The median overall survival for tucatinib in combination with trastuzumab and capecitabine was 21.9 months, compared with 17.4 months for treatment with trastuzumab and capecitabine alone. HER2CLIMB also studied the ability of tucatinib to stop cancer from growing or spreading in patients with brain metastases. Preoperative administration of ribociclib, tucatinib, and trastuzumab with or without fulvestrant may result in smaller tumors and may reduce the amount of normal tissue that needs to be removed.

StrongCYP3Ainducers or moderateCYP2C8inducers, avoid simultaneous use. StrongCYP2C8inhibitors, avoid concomitant use, if concomitant use cannot be avoided, reducetucatinib dose. CYP3Asubstrates, Avoid concurrent use withCYP3Asubstrates as minimal concentration changes may result in serious or life-threatening toxicity. There is a generic version of this medicine in Bangladesh. The retail price of Everest Pharmaceuticals in Bangladesh is about 150mg for 30 tablets 6000 yuan. The retail price of Ziska Pharmaceuticals in Bangladesh is around 4,500 yuan for 150 mg 30 tablets. If you want to get more high-quality information, you can contact Yaode, and Yaode will do its best to learn more about high-quality overseas drugs for you.

xa0

xa0

xa0

xa0